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 
Abstract—This paper is addressed to expanding our 
understanding of the effects of hypoxia training on our bodies to 
better model its dynamics and leverage some of its implications and 
effects on human health. Hypoxia training is a recommended practice 
for military and civilian pilots that allow them to recognize their early 
hypoxia signs and symptoms, and Scientist Astronaut Candidates 
(SACs) who underwent hypobaric hypoxia (HH) exposure as part of 
a training activity for prospective suborbital flight applications. This 
observational-analytical study describes physiologic responses and 
symptoms experienced by a SAC group before, during and after HH 
exposure and proposes a model for assessing predicted versus 
observed physiological responses. A group of individuals with 
diverse Science Technology Engineering Mathematics (STEM) 
backgrounds conducted a hypobaric training session to an altitude up 
to 22,000 ft (FL220) or 6,705 meters, where heart rate (HR), 
breathing rate (BR) and core temperature (Tc) were monitored with 
the use of a chest strap sensor pre and post HH exposure. A pulse 
oximeter registered levels of saturation of oxygen (SpO2), number 
and duration of desaturations during the HH chamber flight. Hypoxia 
symptoms as described by the SACs during the HH training session 
were also registered. This data allowed to generate a preliminary 
predictive model of the oxygen desaturation and O2 pressure curve 
for each subject, which consists of a sixth-order polynomial fit during 
exposure, and a fifth or fourth-order polynomial fit during recovery. 
Data analysis showed that HR and BR showed no significant 
differences between pre and post HH exposure in most of the SACs, 
while Tc measures showed slight but consistent decrement changes. 
All subjects registered SpO2 greater than 94% for the majority of 
their individual HH exposures, but all of them presented at least one 
clinically significant desaturation (SpO2 < 85% for more than 5 
seconds) and half of the individuals showed SpO2 below 87% for at 
least 30% of their HH exposure time. Finally, real time collection of 
HH symptoms presented temperature somatosensory perceptions (SP) 
for 65% of individuals, and task-focus issues for 52.5% of 
individuals as the most common HH indications. 95% of the subjects 
experienced HH onset symptoms below FL180; all participants 
achieved full recovery of HH symptoms within 1 minute of donning 
their O2 mask. The current HH study performed on this group of 
individuals suggests a rapid and fully reversible physiologic response 
after HH exposure as expected and obtained in previous studies. Our 
data showed consistent results between predicted versus observed 
SpO2 curves during HH suggesting a mathematical function that may 
be used to model HH performance deficiencies. During the HH study, 
real-time HH symptoms were registered providing evidenced SP and 
task focusing as the earliest and most common indicators. Finally, an 
assessment of HH signs of symptoms in a group of heterogeneous, 
non-pilot individuals showed similar results to previous studies in 
homogeneous populations of pilots. 
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I. INTRODUCTION 
TMOSPHERIC flight poses various stresses to human 
physiology; modern aerospace operations counteract 
human limitations with leading-edge technology in order to 
mitigate safety risks. One of these safety risks is physical and/ 
or cognitive impairment preventing flight crews to perform 
flight duties in a safe manner, and HH is one of the main 
hazards that might lead to impaired performance. Hypoxia can 
be defined as the incapacity for cells, tissues, and organs to 
utilize oxygen, interfering with normal cellular respiration 
processes [2], [5]. These oxygen utilization abnormalities can 
occur during the uptake, pulmonary ventilation, bloodstream 
transport or oxygen usage by the cells and tissues, which 
results in deteriorated performance in terms of sensory 
perception, psychomotor abilities, cognitive resources, and 
complex decision-making [26]. Examples of hypoxia signs are 
rapid breathing, poor coordination, lethargy, executive 
impairment, and poor judgment, cyanosis (bluish tone of the 
skin), diaphoresis (sweating), trembling, and myoclonic 
(muscle) spasms. Along with hypoxia signs, subjects can 
develop hypoxia symptoms, such as air hunger, fatigue, 
nausea, headache, dizziness, hot-cold flashes, tingling, visual 
impairment, euphoria, and tachycardia [8]-[10], [23]. Various 
studies have reported hypoxia symptoms at various altitudes 
depending on the individual level of susceptibility. For 
example, hypoxia symptoms are visible in most healthy 
individuals after reaching 10,000 ft., but it may be present at 
lower altitudes for some individuals and be absent at higher 
altitudes for some other participants [12]. Other studies state 
that hypoxia symptoms may occur in healthy personnel at 
altitudes higher than 11,811 ft. (3,600 m) and most incidents 
related to hypoxic states have occurred at altitudes below 
19,000 ft. (5,791 m) [23].  
Because of the hazard of flawed human performance, HH 
has been a long-lasting concern for aerospace safety [11]. 
Even though real-time data related to human performance in 
real-world operations is hard to retrieve and analyze, 
numerous simulation scenarios and performance models have 
been developed in order to study signs, symptoms, and 
precursors to human impairment and incapacitation due to 
hypoxic states. HH has been linked with impairment in 
various aspects of human performance [31]. It is well 
established that its effects on the central nervous system 
(CNS) are not only the most relevant in terms of human 
performance but also, the first ones to be evident, especially in 
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oxygen-avid tissues such as the retina [27]. Relevant results in 
hypoxia research indicate that exposed individuals may 
experience mild decrements in reaction time as low as 10,000 
ft., but overall, HH produced consistent detrimental effects on 
short-term memory, pattern recognition, and psychomotor 
skills in altitude settings above 10,000 ft. Moreover, it is 
understood that some cognitive functions remain slightly 
impaired during a brief post-exposure window [1], [3], [7], 
[26]. In addition, hypoxia effects [25] on cognitive abilities are 
strongly related to the complexity of the tasks and the 
vulnerability of the different cognitive functions to be 
affected, showing that mathematical and auditory processing 
are especially prone to hypoxic conditions [7]. It is also widely 
accepted that HH effects, especially those on the CNS, rely 
not only on the exposure altitude (which dictates the relative 
partial oxygen pressure (PO2) of the environment), but also the 
onset and the duration of the exposure to that reduced PO2. 
It is accepted that the onset, intensity, and development of 
subjective sensations derived from HH exposure are widely 
variable. That erraticism has been evident in most of the 
research protocols related to HH and is linked mainly to 
epigenetic influences and exposure variability, but also due to 
the transposition of hypocarbia symptoms, usually associated 
with early hypoxia exposure [26], [29], [33]. Various HH 
training and research protocols include validated acute 
mountain sickness (AMS) scales for reporting HH symptoms, 
but most of these inventories include a closed list that not 
always reflect all HH possible symptoms [27]. It is also known 
about HH symptoms assessment that the extent to which 
memory impairment can affect the recalling of perceptions 
and sensations of the participants during HH exposure might 
be an issue. Knowing that memory is one of the most fragile 
human cognitive resources and retention and encoding are 
certainly impaired by HH, it is expected that symptoms 
recalling, and recognition would also be affected during and 
after HH exposure [35]. Nevertheless, understanding and 
recalling hypoxia symptoms is critical for aircrews so they can 
make critical safety decision [13], [17], [34] such as donning 
emergency oxygen systems, performing an emergency 
descent, looking after smoke or toxic fumes or even 
evacuating the aircraft; all of this while ideally maintaining 
constant communications with ground stations [15]. To that 
end, hypobaric training for crews is an essential tool that 
allows crewmembers to experience and assess their own 
hypoxia signs and symptoms, so they can recognize HH states 
and trigger remedial actions. The goal of HH training is to 
expose participants to a hypobaric environment (altitude 
chamber), inducing signs and symptoms associated with 
hypoxia that the participants can recognize on their own 
bodies, and to demonstrate cognitive deterioration during the 
exposure [32]. Hypoxia physiology training has been 
recommended by international safety regulators for a long 
time. Furthermore, the International Association for the 
Advancement of Space Safety (IAASS) recommends HH 
training for spaceflight operations, including the suborbital 
domain.  
The Polar Suborbital Science in the Upper Mesosphere 
(PoSSUM) is a non-profit organization with a goal to study 
the noctilucent clouds in the mesosphere to enhance our 
understanding of the aeronomy and climate change science. 
PoSSUM program has been training over 100 subjects with 
diverse backgrounds, ethnicity, gender and age since 2015. As 
part of their training, subjects from across the globe meet to 
conduct different scientific activities related to human air and 
space exploration. The HH training takes place at the Southern 
Aeromedical Institute (SAMI) in Melbourne, Florida. 
In this study, we assessed the effects of exposure to HH on 
various subjects during their training in a hypobaric 
environment. Thus, this observational-analytical study 
describes physiological responses experienced by PoSSUM 
participants and proposes a mathematical model which could 
be used to predict levels of oxygen desaturation as a function 
of pressure, during exposure to HH and during recovery after 
donning the oxygen mask to facilitate oxygen delivery.  
II. PROCEDURE AND METHODS 
A. Subjects 
This study was based on a research protocol reviewed and 
approved by the Institutional Review Board (IRB) at Embry-
Riddle Aeronautical University, Daytona Beach campus. Each 
participant or subject, referred to as SAC [19], provided 
written informed consent before taking part in the hypobaric 
runs. These SACs had previously obtained a valid FAA Class 
III medical certificate and were asked to fill a pre-exposure 
health assessment questionnaire (template is attached as 
supplemental information) used for screening common health 
condition. 
Initially, 40 subjects participated in the hypobaric training. 
Out of these, 18 subjects wore real-time registering wearables 
before and after the chamber flight, and the data from these 
subjects will be analyzed. 
All subjects were active individuals who exercised less than 
5 days a week and were not considered part of an elite 
population of athletes (exercise more than 5 days a week). 
B. Materials 
Each subject wore a Zephyr® Bioharness (ZB) [36] to 
collect physiological data before and after the hypobaric 
flight: ZBs recorded HR, BR, core [22] and device 
temperatures (T), and posture. In addition, other hemodynamic 
values, such as systolic pressure (SP), diastolic pressure (DP) 
and mean arterial blood pressure (MAP) were also collected 
before and after each hypobaric flight in the chamber using a 
wgnbpa-945 sphygmomanometer [20]. During the exposure, 
individuals always wore a SPO medical pulse oximeter sensor, 
which provided continuous readings of blood oxygen levels 
(Blood O2 saturation (SpO2)) and HR. This device was placed 
at the index fingertip and had USB capability to be connected 
to a computer where channels SpO2 and pulse rate was 
recorder. The SAMI provided hypoxia training to the subjects. 
The hypobaric chamber, founded in 1999, has trained over 
3,000 pilots to help pilots better understand the dangers of 
“slow onset hypoxia” or altitude sickness. The SAMI 
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personnel as observers from outside the hypobaric chamber 
detected these symptoms or sensations. Expert SAMI 
personnel observed on screens outside the chamber, looking 
for HH signs and symptoms in the subjects during the 
hypobaric flight. Quantitative and qualitative data were 
collected by SAMI observers: They registered vital signs, HH 
signs and symptoms and the overall performance of the 
participants during the exposure. SAMI was equipped with 
Zodiac Aerospace EROS MC 10 MXP6 oxygen mask that was 
worn by SACs when they reached a hypoxic state which was 
articulated by the SAMI personnel.  
All data were collected, analyzed and processed in 
Microsoft Excel software. Data are presented as mean ± 
standard deviation (SD) for each subject. 
C. Hypobaric Chamber Environment 
For each hypobaric run, two SACs entered the hypobaric 
chamber at a time, and an additional third subject from SAMI 
joined them inside the chamber as a support technician. Each 
SAC took a different station where a TBM 850 flight training 
simulator was set. Each subject wore a communication headset 
to communicate with the support staff inside the chamber and 
with SAMI support personnel outside the chamber. Subjects 
were asked to report HH symptoms using this communication 
device in order to be registered by the observing personnel in 
real-time. An oxygen mask was placed next to each station 
and a pulse oximeter sensor was set on each candidate’s index 
registering the saturations of oxygen (SatO2) continuously.  
D. Hypobaric Exposure 
Participants were instructed for 30 minutes about “slow 
onset hypoxia” including a basic introduction to aviation 
physiology, and a review of accidents due to slow-onset 
hypoxia. After this short lecture, participants were given a 30-
minutes pre-flight orientation about the flight simulators and 
oxygen mask utilization (emergency mask donning), then, 
participants entered the hypobaric chamber for approximately 
30 minutes. The high-altitude chamber training flight started at 
5,000 ft. with an ascent rate of about 2,000 ft. per minute, the 
SACs were then asked to perform a flight-training task (FTT), 
with the objective of following certain flight vectoring 
directions as instructed by SAMI personnel. During the FTT, 
the participants were also asked to be alert of arising HH 
symptoms derived from this slow-onset hypoxia exposure. 
First, the SAMI personnel began to decrease the cabin 
pressure up to 5,000 ft to slowly adapt the subjects to pressure 
shifts, and then the cabin pressure was brought back to ground 
altitude. Following, the cabin pressure was decreased until 
approximately 20,000-22,000 ft. high equivalent. SAMI 
personnel closely monitored the participants while 
maintaining constant communication with them ascertaining 
their individual hypoxia sensations. Every 2,000 ft (or 1 
minute given the normal average rate of climb), SAMI 
personnel inquired about the state of the subjects and asked 
the current reading of SpO2 in their respective pulse 
oximeters. Subjects felt either hypoxia symptoms or were 
instructed by the flight controller from the air traffic control 
station about their low levels of oxygen, at that time subjected 
were instructed to don their masks (with 100% oxygen) by 
removing first their headsets, while being aided by the support 
staff inside the chamber. 
SAMI safety procedures recommended that SACs 
hypobaric exposure should not go above 22,000 ft. When the 
SAMI personnel observed hypoxia signs or symptoms, 
subjects were asked to don their oxygen mask and breathe 
100% to correct their hypoxic state. Lastly, subjects were 
provided a 30 minutes post-flight review of flight video, 
oxygen saturation levels, and sensations during their flight 
training in the hypobaric chamber.  
E. Data Collection 
Data collection was conducted during 4 research campaigns 
at SAMI. The first two campaigns occurred simultaneously in 
October 2015, the third campaign was 6 months after the first 
two, and the fourth campaign took place 6 months after the 
third one. 
Vital signs and physiological variables (HR, BR, T, SP, DP, 
MAP, SpO2) were recorded for each participant using the ZB 
wearables for 10 minutes before and after each hypobaric run, 
ZB devices were not allowed inside the chamber because they 
are powered by lithium batteries. SpO2 and HR were always 
measured and monitored when the participants were inside the 
chamber while SAMI support personnel recorded both the 
number of desaturations and duration of each desaturation. 
SAMI personnel recorded relevant data from the flight 
profile inside the hypobaric chamber from about 9,000 ft – 
10,000 ft during the ascent to about 17,000 – 20,000 ft during 
the descent and after having donned the oxygen mask. This is 
the range in altitude where subject’s physiology started being 
affected. Flight duration ranged from about 8.5 min to about 
13.5 min inside the chamber. Data collection was done by 
extracting from the recorded video the time, altitude and 
oxygen desaturation level, every 30 seconds in order to plot an 
oxygen desaturation pressure curve for each subject 
(measured), and then compare it with the calculated 
(theoretical) oxygen desaturation pressure curve [5], [6]: 
 
𝑆𝑂  % 100 ∙ 23400 ∙ 𝑃𝑂 150 ∙ 𝑃𝑂 1  (1) 
 
This is referred to as the Severinghaus modified existing 
curve (previously by [14]) in 1979, which represents a more 
accurate expression than the previous Hill expression [14]. 
The partial pressure of oxygen was obtained using the 
following expression for every altitude point: 
 
𝑃𝑂 𝑘𝑃𝑎 101.325 ∙  1 6.87535 ∙ 10 ∙ 𝐴𝑙𝑡 𝑓𝑡
.
(2) 
 
where the pressure is given in kPa and the altitude in feet. 
Altitude was obtained from the video-recorded flight data, 
then use to obtain PO2 in (2). Then, the value obtained in (2) 
was used in (1) to obtain SO2 (%). 
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III. RESULTS 
Study subjects ranged between 23 and 58 years old with a 
mean age of 34.75 with a SD of 9.37 years (34.8 ± 9.4). Out of 
18 subjects, 16 were male (89%) and two females.  
Among the 18 subjects, 90% of these were not taking any 
medication, 5% were taking only multivitamins and the other 
5% were taking analgesics or allergy pills. PoSSUM 
campaigns occurred twice a year, during October and during 
March (strong allergy season in Daytona Beach, Florida). 
Only 10% of subjects stated they were current smokers and 
50% of the subjects said they consume alcohol between two 
times and six times a week. 15% of subjects stated they had 
some sort of oral surgery and 25% had other associated 
surgeries relating their knee, back, hips, shoulder or neck. 
Only 7.5% of subjects indicated they had some sort of 
gastrointestinal issues in the past, and although this number 
represents only 3 subjects among the 18 subjects, we will see 
later that the gastrointestinal score is one of the variables most 
affected in subjects. 
About 11% of the SACs started experiencing their first 
symptoms at about 11,000 ft and were not allowed to fly 
higher than FL170 or FL180 per SAMI personnel safety 
decisions (who were constantly monitoring SACs vitals during 
their flight inside the hypobaric chamber. Participants were 
answering SAMI’s questions verbally), at that time they were 
told to don their masks. About 78% of SACs started to feel 
first symptoms between 15,000 ft and 18,000 ft, second 
symptoms at about 20,000 ft and third symptoms at about 
21,500 ft. SACs donned their masks when they recognized 
their third symptoms. Some participants had to don their 
masks about 20,000 ft. Only 2 participants (11% of 
participants) did not develop several symptoms, but they were 
asked to don their mask at about FL220 to avoid high altitude 
cabin depressurization [24]. Recovery was very fast and 
within 30 seconds to 1 minute of donning their mask, SACs 
recovered their normal state without any hypoxia symptoms. 
SACs recovered most of their cognitive skills after oxygen 
mask was donned.  
 
 
Fig. 1 Oxygen saturation (SpO2) level and their corresponding time at 
that level for 20 subjects. Dashed line represents the average of all 
data 
 
Results (Fig. 1) indicate that all 18 SACS spent about 
70.2% of the time at 100-94% SpO2 with a total of 5 
desaturations, followed by 10.6% of the time with 56 
desaturations at 93-88% SpO2, followed by 6.6% of the time 
with 45 desaturations at 87-80% SpO2, followed by 5.3% of 
the time with 37 desaturations at 79-70% SpO2, followed by 
3.3% of the time with 22 desaturations at 69-60% SpO2, 
followed by 1.2% of the time with 11 desaturations at 59-50% 
SpO2. None of the SACs spent any time or had any 
desaturations at 49-40% SpO2. Fig. 1 shows the SpO2 
distribution for all 18 SACs. The solid dash line indicates the 
average time for each level of desaturation. The lowest SpO2 
among all SACs is 66.7% with a SD of 10.9%, and the mean 
SpO2 is 93.2% with a SD of 2.7%. All SACs had a maximum 
SpO2 of 99%. Fig. 2 displays the individual SpO2 distribution 
for the subjects. 
A. Hypobaric Chamber Analysis 
The average of the highest PR among the 20 SACs is 
114.95 bpm with a SD of 17.96. The average of the lowest PR 
is 59.6 bpm with a SD of 11.64, and 88.40 with a SD of 16.23 
for the average of the mean PR. 
Fig. 3 shows the oxygen desaturation pressure curves 
(measured and calculated) for each participant. The measured 
data (every 30 seconds) are portrayed in orange with every 
data point as a square, and the calculated data are given in 
grey (data point is triangle). The blue dashed line corresponds 
to the polynomial fit (6th order) of the measured oxygen with 
the pulse oximeter. Table I provides the coefficients for each 
of the polynomial fit and the correlation coefficient. 
From the above analysis, we suggest two main groups 
during hypobaric exposure. The first group is subjects 3, 4, 5, 
7, 8, 10, 12, 13, 14, 15 and 17; second group is subjects 1, 2, 
6, 9, 11, 16, and 18. These groups were analyzed by inspecting 
the polynomial coefficients. We took an average of each of the 
above polynomial coefficients for each group so that the 
polynomial fit has the form: 
 
𝑦1 0.00115 𝑥 0.037 𝑥 0.4668 𝑥
2.9487 𝑥  9.5294 𝑥 14.4397 𝑥 104.334 (3) 
 
with a correlation coefficient of 0.9808. x and y are the 
pressure and oxygen desaturation, respectively. For this group 
(3), coefficients A, E, G > 0 and B, C, D, F < 0. Similarly, the 
second group (4) during exposure adopts a form given by the 
following polynomial: 
 
𝑦2 0.00016 𝑥 0.008257 𝑥 0.15603 𝑥
 1.4112 𝑥 6.2164 𝑥 11.9774 𝑥 90.3036 (4) 
 
with a correlation coefficient R= 0.9799, with B, D, F, G > 0 
and A, C, E < 0. We can label the above two polynomials 
Type I-exposure (3) and Type II-exposure (4) since they have 
different coefficients. Similarly, we obtained two other 
polynomials during recovery phase. The first one (5) follows 
the form: 
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Fig. 2 Oxygen saturation distribution for 18 subjects 
 
𝑦1 0.127264 𝑥 2.7727 𝑥 23.5103 𝑥
96.4506 𝑥 190.7413 𝑥 36.0975           (5) 
 
with R = 0.9944; B, D, F > 0, and C, E, G < 0, and the second 
polynomial (6) follows the form: 
 
𝑦2 0.00037 𝑥 0.02677 𝑥 4.7902 𝑥
 16.0136 𝑥 82.1986 𝑥 66.9366       (6) 
 
 
with R = 0.952; B, C, E < 0, and D, F, G < 0. The first 
polynomial for the recovery phase (Type I-recovery) 
corresponds to subjects 1, 3, 5, 6, 7, 8, 9, 10, 11, 14 and 15. 
The second polynomial for the recovery phase (Type II-
recovery) corresponds to subjects 2, 4, 12, 13, 16, 17 and 18. 
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TABLE I A 
POLYNOMIAL FIT OF OBSERVED SPO2 DURING EXPOSURE 
𝑦 𝐴𝑥 𝐵𝑥 𝐶𝑥 𝐷𝑥 𝐸𝑥 𝐹𝑥 𝐺, 
0 < R = CORRELATION COEFFICIENT < 1 
A B C D E F G R 
-0.0004 0.0174 -0.264 1.8837 -6.46 9.6471 94.154 0.97
-0.0002 0.009 -0.1577 1.3068 -5.25 9.5455 92.364 0.97
0.00008 -0.0038 0.0726 -0.7327 3.8866 -9.3812 104.57 0.98
-0.0003 0.0061 0.0287 -1.1048 6.4751 -12.286 103.11 0.96
-0.00001 0.0004 -0.0046 -0.0019 0.0852 -0.7818 99.511 0.98
0.0001 -0.0018 -0.0348 0.9319 -6.4188 14.401 89.056 0.95
0.00004 -0.0017 0.0257 -0.231 1.3553 -4.3017 101.59 0.98
0.00005 -0.003 0.0669 -0.763 4.298 -10.077 103.19 0.99
-0.0003 0.0133 -0.2522 2.2605 -9.7004 17.927 87.431 0.99
0.0003 -0.0151 0.2444 -1.8512 6.7433 -11 103.99 0.98
-0.0002 0.0113 -0.2187 2.0355 -9.1197 17.318 85.948 0.97
0.0011 -0.0396 0.5609 -3.79 12.266 -16.454 102.64 0.98
0.00001 -0.0008 0.0205 -0.2394 1.3249 -3.1353 100.26 0.98
0.0022 -0.0664 0.7791 -4.3892 12.088 -14.542 103.17 0.99
0.0092 -0.2834 3.3383 -19.091 54.959 -74.343 129.43 0.93
-0.00002 0.0017 -0.0395 0.3738 -1.9475 5.9451 90.872 0.99
0.00001 -0.0008 0.00207 -0.2413 1.3415 -2.5347 96.223 0.98
-0.0001 0.0069 -0.1253 1.0859 -4.6181 9.0582 92.3 0.99
 
 
TABLE I B 
POLYNOMIAL FIT OF OBSERVED SPO2 DURING RECOVERY 
𝑦 𝐵𝑥 𝐶𝑥 𝐷𝑥 𝐸𝑥 𝐹𝑥 𝐺, 
0 < R = CORRELATION COEFFICIENT < 1 
B C D E F G R 
0.0208 -0.4659 3.8504 - 14.375 24.538 -2.825 0.99
-0.0583 1 - 6.0417 14 3.9 81 1 
0.2667 -5.25 40.167 -149.25 269.07 89 1 
0.0212 0.5673 - 5.4006 20.388 16.622 58.333 0.99
0.0063 -0.2452 3.6288 -25.394 83.016 - 1.0804 0.98
0.0481 - 1.3234 13.948 -69.76 163.25 -46.667 0.97
0.0631 -1.7057 17.687 -86.551 195.08 -62.5 0.99
0.0532 -1.4674 15.457 -77.167 180.52 -59 0.98
0 -2.4167 32.667 - 158.58 326.33 -143 1 
0 0 4.1667 - 39 117.83 16 1 
0.225 -4.25 31.208 -112.25 200.07 - 45 1 
0.0356 -0.9468 9.5508 -45.504 102.21 11.75 0.78
0 -1.8333 24.667 -119.17 244.33 82 1 
0.25 -4.5417 32 -109.96 185.25 -24 1 
0.4667 -8.8333 63.833 -218.67 353.2 -118 1 
-0.0044 0.0843 -0.0949 -6.9857 47.077 12.067 0.97
-0.0335 0.9914 -10.735 50.218 -86.023 101.6 0.98
0.0004 -0.0503 1.1755 -10.903 43.931 35.533 0.98
 
 
(a) Oxygen desaturation curves for subjects 1 and 2 
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(b) Oxygen desaturation curves for subjects 3 and 4 
 
 
(c) Oxygen desaturation curves for subjects 5 and 6 
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(d) Oxygen desaturation curves for subjects 7 and 8 
 
 
(e) Oxygen desaturation curves for subjects 9 and 10 
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(f) Oxygen desaturation curves for subjects 11 and 12 
 
 
(g) Oxygen desaturation curves for subjects 13 and 14 
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(h) Oxygen desaturation curves for subjects 15 and 16 
 
 
(i) Oxygen desaturation curves for subjects 17 and 18 
Fig. 3 Oximeter desaturation pressure curves (measured and calculated) for 18 subjects 
 
Participants experienced several desaturations during their 
hypobaric chamber training as depicted in Fig. 4. Most of 
these desaturations are negligible in terms of oxygen 
desaturation percentage and duration; however, we highlight 
the main desaturation(s) for each subject (Fig. 3). Subjects 1 
and 2 are displayed in Fig. 3 (a), subjects 3 and 4 are shown in 
Fig. 3 (b), subjects 5 and 6 are depicted in Fig. 3 (c), subjects 
7 and 8 are presented in Fig. 3 (d), subjects 9 and 10 are 
displayed in Fig. 3 (e), subjects 11 and 12 are shown in Fig. 3 
(f), subjects 13 and 14 are depicted in Fig. 3 (g), subjects 15 
and 16 are presented in Fig. 3 (h), and subjects 17 and 18 are 
shown in Fig. 3 (i). Subject 1 experienced no major 
desaturations. Subject 2 experienced a desaturation at 86%, 
129 bpm for five seconds (contrast against graph for SAC 2). 
Subject 3 registered a main desaturation at 66%, 120 bpm, for 
five seconds. Subject 4 had a desaturation at 57%, 106 bpm 
for five seconds. Subject 5 experienced a desaturation at 59%, 
117 bpm for 5 seconds. Subject 6 showed a SatO2 at 59%, 47 
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bpm for ten seconds. 
Subject 7 had a desaturation at 62%, 92 bpm for five 
seconds. Subject 8 experienced a desaturation at 58%, 61 bpm 
for five seconds. Subject 9 had a desaturation at 55%, 120 
bpm for five seconds. Subject 10 experienced a desaturation at 
67%, 99 bpm for five seconds. Subject 11 experienced two 
main desaturations: first at 80%, 105 bpm; second at 70%, 111 
bpm for five seconds each. Subject 12 had a desaturation at 
77%, 119 bpm for five seconds. Subject 13 registered a main 
desaturation at 66%, 117 bpm, for five seconds. Subject 14 
experienced a desaturation at 79%, 99 bpm, for five seconds. 
Subject 15 had a SatO2 at 72%, 143 bpm, for five seconds. 
Subject 16 had a main desaturation at 53%, 111 bpm, for 20 
seconds. Subject 17 registered a main desaturation at 56%, 
139 bpm, for five seconds. Finally, subject 18 experienced a 
SatO2at 70%, 139 bpm, for five seconds. 
 
 
Fig. 4 Oxygen saturation and number of desaturations for 18 subjects 
 
Fig. 4 shows the number of desaturations for each subject. 
For example, SAC 1 only experienced 3 desaturations as 
indicated in the middle of the slice, which occurred between 
93% – 88% (see Fig. 2). 
During this study, several symptoms were identified in all 
40 SACs. It is important to highlight that before reaching 
18,000 ft all participants had reported at least the first hypoxia 
symptom. The two most common symptoms experienced by 
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the participants were SP, especially temperature related (hot or 
cold sensation), and concentration deficit (Fig. 5). This 
temperature feeling [4] occurred in face and hands mainly, 
while the concentration deficit meant that the SAC had a hard 
time to focus on the given task, or had some type of visual 
tracking scan deficit that made subjects spend more effort to 
scan and made given inputs by the air traffic control station, or 
loss control of the joystick, or had a hard time remembering 
some of the commands given by the SAMI crew. These two 
symptoms were experienced by 65.0% and 52.5% of the 
participants, respectively. The next three common symptoms 
SACs experienced were light-headed, tingling and nausea 
feeling by 32.5%, 27.5% and 25.0% of the participants, 
respectively. The third set of symptoms, such as grainy and 
tunnel vision, ears pressure or pounding, and increased HR 
feeling and palpitations were also experienced by 20.0%, 
20.0%, and 12.5% of the participants, respectively. Finally, 
other symptoms were also experienced by a few SACs. 
Example of these symptoms were numbness in the lips and 
fingers that prevented the participants to articulate properly as 
is reflected in their speech being difficult for communication 
with SAMI personnel, changes in breathing, and general 
psychomotor symptoms which could have affected the 
manipulation of the joystick as they were flying the simulator 
inside the hypobaric chamber. These last three symptoms 
resulted in 10.0%, 10.0%, and 17.5%, respectively.  
 
 
Fig. 5 Hypoxia symptoms for 40 subjects 
 
Numerous antecedents in HH research used validated AMS 
scales for collecting HH symptoms, but the myriad of 
symptoms observed during this study, and their distribution 
and presentation among this group of SACs, advises for an 
open list of sensorial perceptions rather than the few included 
in the mentioned AMS scales.  
IV. DISCUSSION 
Previous studies [18] spatial memory impairment and 
neurodegeneration reported on the downregulation of the brain 
caused by repeated HH exposure.    
This research study dealt with 40 subjects being exposed to 
and hypobaric environment for a short period (order of a few 
minutes) as part of a training for prospective participants in 
suborbital operations. A pulse oximeter device monitored the 
level of oxygen desaturation for each subject during flight in 
the hypobaric chamber. These devices tracked these variables 
for most of the subjects. However, there were a few instances 
where the data were noisy or missing, perhaps due in part to a 
motion artifact or subject movement while flying the simulator 
inside the hypobaric chamber. Because of the previously 
described safety issues, Bioharness instrumentation cannot go 
inside the chamber during flights, which prevented researchers 
to gather valuable HR, BR and other physiological parameters 
inside the chamber and any correlation among these 
parameters. However, the use of the pulse oximeter allowed us 
to at least gather the HR data while inside of the chamber. 
Motion artifact or subject improper movement when 
wearing the pulse oximeter while subjects were in the 
hypobaric chamber may have been a contributing factor to 
inaccuracies in the oxygen desaturation for at least one 
subject, which does not significantly affect the behavior of the 
average curve (for 20 subjects) representing the oxygen 
desaturation and time spent within each percentage bracket 
(e.g. 100%-94% to 49%-40%). Motion artifact could have 
been the main cause why some data were missing when using 
the Bioharness. In the end, we gathered complete data set for 
12 subjects, which was analyzed. 
In our study, as observed in Fig. 1, all subjects spent an 
average of 70% of their time with an oxygen saturation level 
of between 94% to 100%, and about 17% of their time with 
oxygen saturation levels between 80% and 93%; about 5% 
between 70% and 79% and about 4.5% between 50% and 
69%. It is important to note that one subject spent only about 
35% between 94% and 100% blood oxygen saturation levels, 
which was probably an artifact leading to an inconsistent 
measurement, given the subject’s clinical features and 
cognitive function during the exposure were unaffected. 
Neglecting this subject, the average time spent between 94% 
and 100% would be only 2% higher, and 0.5% higher between 
88% and 93%, which suggests that these are very small 
variations. For the rest and lower of the saturation levels, the 
difference would be less than 0.1%. This means that the 
dashed line would be shifted slightly higher these amounts. 
Thus, this single data point (if considered an outlier) does not 
affect the black dashed line significantly. These results are in 
concordance with previous HH research [28] and physiologic 
models predicting that altitudes up to 25,000 ft produce blood 
oxygen desaturation readings in the ranges observed during 
the present study and modeled by classic physiology works 
about oxyhemoglobin and PO2. Oxygen saturation [16] is a 
critical physiological parameter to identify and evaluate 
preflight and post flight. Prospective commercial spaceflight 
ventures will fly participants with smoking history who may 
be more sensitive to cabin pressure and O2 levels variations 
[21]. The Aerospace Medical Association (AsMA) assumes 
that the cabin will be pressurized to sea level (760 mmHg) 
with 80% nitrogen, 20% oxygen atmosphere, and that no life 
support system would be necessary for nominal flights [30]. 
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This means, that there is no requirement for special life 
support equipment, and in the event of off-nominal or 
contingencies scenarios or emergency (e.g. cabin 
decompression or fumes in the cabin) proper measures would 
need to be considered for these critical spaceflight operations, 
such as donning an oxygen mask may be necessary.  
Several important observations can be extracted from this 
study (Fig. 3) based on the polynomial fit of order 6th between 
the oxygen saturation percentage of all subjects and the 
associated pressure curve when in the hypobaric chamber.  
Among the 18 subjects analyzed, we first observed that only 
two subjects experienced oxygen saturation levels higher than 
their associated oxygen saturation levels calculated with 
theoretical curves [6], from (1). Although these curves 
represent higher oxygen saturation levels, they both show a 
similar behavior with a decrease in their levels of oxygen 
(from 98%) saturation as they approach their hypoxic state 
with 93% and 88% oxygen saturation being these their 
minimum. Immediately after donning their masks on, their 
normal oxygen saturation levels (98%) were retrieved after 
one minute. This variation in performance can be explained by 
individual differences such as exercise habits, previous HH 
exposure or cardiovascular epigenetics, just to mention a few 
confounding factors.  
The second important observation is that the next 16 
subjects have oxygen saturation pressure curves with a more 
pronounced behavior. All these subjects experienced slightly 
different experimental curves, each curve started with a 
plateau of their oxygen saturation levels, and it decreased or 
slightly increased momentarily before decreasing again. 
Depending on the subject, this SpO2 decrease varied from 
about three to about five minutes before their SpO2 went 
below their theoretical value obtained from (1). Subjects 
experienced lower SpO2 than their theoretical values for about 
one minute to three minutes. At this point, subjects were told 
they had reached a hypoxic state and asked to don their 
oxygen masks on. With masks on, half of the subjects took as 
low as thirty seconds, and the rest of the subjects took between 
sixty and ninety seconds to retrieve their normal SpO2 (about 
97%-99%). This SpO2 did not remain constant, but instead it 
dropped as much as 2%-4% (SpO2 about 92%-95%) for some 
subjects, then it slightly increased again. These slight 
oscillations were observed in most if not all the subjects with 
varying time length. The shape of the SpO2 curve for these 16 
subjects showed a performance below expected, this deficit 
should be explained by the same confounding factors 
described above, but also showed a consistent pattern that led 
to the third observation. 
The third observation was obtained after analyzing the SpO2 
plots and realizing that graphs of data collected from the 
hypobaric chamber was used to provide a preliminary model 
of the oxygen desaturation and pressure curve for each 
subject, as explained earlier in the hypobaric chamber analysis 
section. Although this analysis was only provided for 18 
subjects, data suggest that a polynomial of sixth order could be 
initially used to predict future physiology and performance 
behavior in a subject while conducting similar tasks in the 
hypobaric chamber. From our data, it is suggested that a 
polynomial of sixth order with various polynomial coefficients 
could be used during exposure since 61% of subjects follow 
Type I-exposure polynomial fit and the rest of subjects follow 
a sixth-order Type 2-exposure polynomial fit. During 
recovery, data suggest that 61% of subjects follow a fifth-
order Type 1-recovery polynomial fit, and the rest of subjects 
follow a fifth-order Type 2-recovery polynomial fit. More 
subjects will be required to further optimize the nature of the 
polynomial that fits the experimental (oxygen desaturation) 
data.  
Analyzing the distribution of all the symptoms experienced 
and reported by all 40 subjects, three main groups can be 
extracted. The first group (> 50%-55% of subjects experienced 
these symptoms) includes the two most frequent symptoms as 
reported by previous research, such as cold or warm flashes 
[9], [10] in their chest or face and difficulty on concentrating 
in the task conducted in the chamber. The second group (> 
20%-25% of subjects experienced these symptoms) includes 
lightheadedness, tingling in the subject’s hands, dizziness/ 
nausea and vision issues while conducting the task. The last 
group (< 13% of subjects experienced these symptoms) 
includes other minor symptoms, such as pressure in the ears, 
HR variability, speech or communication problems and 
breathing issues among a minority of the participants. 
The real-time reporting and recording of HH symptoms 
carried during the present study allowed researchers to collect 
and analyze very granular data related to not only the type of 
symptoms, but also time of onset and cumulative symptoms 
during the whole extent of the hypobaric session. This 
procedure allowed better analysis and discussion of 
perceptions related to HH and prevented data loss due to 
expected memory deficits during the HH exposure. This might 
be important for other HH training programs where the 
subjects are asked to remember and report their symptoms 
after the hypobaric session. Also, for training programs using 
AMS scales for HH symptoms assessing, these results might 
suggest that those validated scales might disregard some other 
symptoms and may not be the best fit for HH training. 
V. CONCLUSION 
HH is a major stress factor associated with physiological 
alterations. This study has shown that a heterogeneous group 
of subjects under physiological stressors such as HH presented 
known signs and symptoms directly relatable to oxygen 
deprivation, leading to impairments in superior cognitive 
function, which is one of the most important requirements for 
safe flight operations. After a standard HH exposure, the 
participants of this study showed predictable affectations 
described by previous research [3], [7], [11], [14], [28], [31] 
and modeled by traditional and widely accepted respiratory 
physiology models. Furthermore, the observations and 
analysis from this research demonstrated the insidious and 
fully reversible onset of HH signs and symptoms depending 
directly on PO2, SpO2 variations, and the individual variables 
affecting this relationship. Real-time reporting and recording 
of HH symptoms described in this research evidenced SP and 
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task focusing as the earliest and most common indicators; the 
SAC group participating in this study reported a diverse 
inventory of sensations and perceptions concurring around 
known and recognized warning signs that might alert 
individuals exposed to mild and moderate HH.  
 A 6th order polynomial fit indicates that predicted SpO2 
and observed SpO2 curves for this group of individuals present 
very similar behavior between subjects during a standard HH 
exposure, suggesting a predictive model of SpO2 during 
hypoxia, such a model should be tested and refined by further 
research that might be able to project this model as a major 
performance moderator in hypoxia and hypobaric activities.  
Due to the high relevance of HH as a potential human 
performance hazard affecting the safety of aerospace 
operations, hypoxia training is an effective practice aiming to 
mitigate preventable operational risks. This assessment of HH 
signs and symptoms reveals that hypoxia training on SACs 
retrieved comparable physiologic results and reported 
symptomatology to previous HH research performed in 
homogeneous aviator populations, and allowed researchers to 
propose a modeling function for predicting human 
performance in terms of blood oxygen saturation and altitude 
exposure, that might contribute to prevent cognitive 
dysfunction in safety-critical activities.  
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